Physician profile
Danielle R Davis
NPI 1639328743
$922.68
in general payments reported to CMS, 2019-2025
17 companies · $417 in 2025
The $417 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $115 · 2021: $83.10 · 2022: $122 · 2023: $44.24 · 2024: $34.23 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $166.60 | 2025 | Azstarys |
| Glaxosmithkline, LLC. | $162.19 | 2019-2025 | Pediarix, Bexsero, Penmenvy |
| Takeda Pharmaceuticals U.S.A., INC. | $107.80 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $67.84 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $67.23 | 2019-2022 | |
| Pfizer INC. | $55.31 | 2019-2025 | |
| Sanofi Pasteur INC. | $54.20 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $45.08 | 2022-2025 | Vaxneuvance, Gardasil 9, M-M-R II |
| Supernus Pharmaceuticals, INC. | $35.02 | 2022-2025 | Qelbree |
| Alk-Abello, INC | $30.32 | 2025 | Neffy, Odactra, Grastek |
| Seqirus USA INC | $28.04 | 2022-2023 | Flucelvax Quadrivalent |
| Shire North American Group INC | $19.37 | 2019 | |
| Tris Pharma INC | $19.24 | 2020 | |
| Cranial Technologies, INC | $19.04 | 2024 | Doc Band |
| Genentech USA, INC. | $15.63 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $15.32 | 2025 | |
| Neos Therapeutics, LP | $14.45 | 2025 | Cotempla Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.